Impact of multimorbidity patterns on outcomes and treatment in patients with coronary artery disease
European Heart Journal Open · 01.03.2024 · 4 (2)
DOI: 10.1093/ehjopen/oeae009 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal Open, online erschienen am 27.03.2024. Verfasst von Wen Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing 100029, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, Beijing Hospitals Authority Youth Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
With an aging population and better survival rates, coronary artery disease (CAD) with multimorbidity has become more prevalent, complicating treatment and impacting life quality and longevity. This study identifies multimorbidity patterns in CAD patients and their effect on clinical outcomes, emphasizing treatment strategies. Methods and results The study analysed data from the DCEM registry (173 459 patients) and BleeMACS cohort (15 401 patients) to categorize CAD patients into three multimorbidity patterns. The focus was on how these patterns influence outcomes, especially concerning the efficacy and safety of dual antiplatelet therapy (DAPT). The study identified three distinct multimorbidity patterns: Class 1 encompassed cardiovascular–kidney–metabolic comorbidities indicating the highest risk; Class 2 included hypertension–dyslipidaemia comorbidities, reflecting intermediate risk; and Class 3 involved non-specific comorbidities, indicating the lowest risk. Class 1 patients demonstrated a six-fold increase in in-hospital mortality and a four-fold increase in severe in-hospital complications compared with Class 3. Over a 1-year period, Class 1 was associated with the highest risk, displaying a significant increase in all-cause mortality [adjusted hazard ratio (HR) 1.87, 95% confidence interval (CI) 1.52–2.31, P < 0.001] and a notable risk for major bleeding (adjusted HR 1.74, 95% CI 1.36–2.24, P < 0.001) compared with Class 3. The use of DAPT, particularly aspirin combined with clopidogrel, significantly reduced the 1-year all-cause mortality in Class 1 patients (adjusted HR 0.60, 95% CI 0.37–0.98, P = 0.04) without increasing in major bleeding.
Conclusion
Coronary artery disease patients with a cardiovascular–kidney–metabolic profile face the highest mortality risk. Targeted DAPT, especially aspirin and clopidogrel, effectively lowers mortality without significantly raising bleeding risks. Registration DCEM registry (NCT05797402) and BleeMACS registry (NCT02466854).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing 100029, China.
- Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, No.10 Tieyi Road, Haidian District, Beijing 100000, China.
ORCID-Profile: Shaoping Nie
Förderung
- National Key Research and Development Program of China
- Beijing Hospitals Authority Youth Program
- National Natural Science Foundation of China
Zitieren
APA
Zheng, W., Huang, X., Wang, X., Suo, M., Yan, Y., Gong, W., Ai, H., Que, B., & Nie, S. (2024). Impact of multimorbidity patterns on outcomes and treatment in patients with coronary artery disease. European Heart Journal Open, 4(2). https://doi.org/10.1093/ehjopen/oeae009
Vancouver
Zheng W, Huang X, Wang X, Suo M, Yan Y, Gong W, et al. Impact of multimorbidity patterns on outcomes and treatment in patients with coronary artery disease. European Heart Journal Open. 2024;4(2). doi:10.1093/ehjopen/oeae009
BibTeX
@article{Zheng2024,
author = {Zheng, Wen and Huang, Xin and Wang, Xiao and Suo, Min and Yan, Yan and Gong, Wei and Ai, Hui and Que, Bin and Nie, Shaoping},
title = {Impact of multimorbidity patterns on outcomes and treatment in patients with coronary artery disease},
journal = {European Heart Journal Open},
year = {2024},
volume = {4},
number = {2},
doi = {10.1093/ehjopen/oeae009}
}
EUVIMED